Medisights Pioneers New Standard: AI Agents Capture Unprecedented Near Real-Time Market Intelligence in Complex Diseases Like Multiple Myeloma
NEW YORK, Sept. 16, 2026 /PRNewswire/ -- Medisights, the AI-native platform for life sciences, today announced the successful completion of a landmark study demonstrating that purpose-built Artificial Intelligence (AI) agents can seamlessly navigate the intricate, rapidly evolving...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.